CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager

CASI Pharmaceuticals Inc

NASDAQ:CASI

Watchlist

Dividends

Price: 5.55 USD -0.89% Market Closed

Market Cap: 74.4m USD

Have any thoughts about
CASI Pharmaceuticals Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 5.55 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CASI Alert

CASI Pharmaceuticals Inc

5.55

-0.05 (-0.89%)

52 Week Range	2.24 7.85
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

CASI Pharmaceuticals Inc

What unique competitive advantages
does CASI Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does CASI Pharmaceuticals Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of CASI Pharmaceuticals Inc.

What unique competitive advantages
does CASI Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does CASI Pharmaceuticals Inc face in the near future?

Summarize the latest earnings call
of CASI Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CASI Pharmaceuticals Inc.

Provide P/S
for CASI Pharmaceuticals Inc.

Provide P/E
for CASI Pharmaceuticals Inc.

Provide P/OCF
for CASI Pharmaceuticals Inc.

Provide P/FCFE
for CASI Pharmaceuticals Inc.

Provide P/B
for CASI Pharmaceuticals Inc.

Provide EV/S
for CASI Pharmaceuticals Inc.

Provide EV/GP
for CASI Pharmaceuticals Inc.

Provide EV/EBITDA
for CASI Pharmaceuticals Inc.

Provide EV/EBIT
for CASI Pharmaceuticals Inc.

Provide EV/OCF
for CASI Pharmaceuticals Inc.

Provide EV/FCFF
for CASI Pharmaceuticals Inc.

Provide EV/IC
for CASI Pharmaceuticals Inc.

Show me price targets
for CASI Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for CASI Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for CASI Pharmaceuticals Inc?

What are the Net Income projections
for CASI Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for CASI Pharmaceuticals Inc?

What are the EPS projections
for CASI Pharmaceuticals Inc?

How accurate were the past EPS estimates
for CASI Pharmaceuticals Inc?

What are the EBIT projections
for CASI Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for CASI Pharmaceuticals Inc?

Compare the revenue forecasts
for CASI Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CASI Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CASI Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of CASI Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of CASI Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing CASI Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of CASI Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for CASI Pharmaceuticals Inc.

Provide ROE
for CASI Pharmaceuticals Inc.

Provide ROA
for CASI Pharmaceuticals Inc.

Provide ROIC
for CASI Pharmaceuticals Inc.

Provide ROCE
for CASI Pharmaceuticals Inc.

Provide Gross Margin
for CASI Pharmaceuticals Inc.

Provide Operating Margin
for CASI Pharmaceuticals Inc.

Provide Net Margin
for CASI Pharmaceuticals Inc.

Provide FCF Margin
for CASI Pharmaceuticals Inc.

Show all solvency ratios
for CASI Pharmaceuticals Inc.

Provide D/E Ratio
for CASI Pharmaceuticals Inc.

Provide D/A Ratio
for CASI Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for CASI Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for CASI Pharmaceuticals Inc.

Provide Quick Ratio
for CASI Pharmaceuticals Inc.

Provide Current Ratio
for CASI Pharmaceuticals Inc.

Provide Cash Ratio
for CASI Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for CASI Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for CASI Pharmaceuticals Inc?

What is the current Free Cash Flow
of CASI Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for CASI Pharmaceuticals Inc.

CASI

Income Statement

Income to Minority Interest

CASI Pharmaceuticals Inc
Income to Minority Interest

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

CASI Pharmaceuticals Inc
Income to Minority Interest Peer Comparison

Comparables:

ABBV

GILD

AMGN

VRTX

REGN

Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors

Company		Income to Minority Interest	CAGR 3Y	CAGR 5Y	CAGR 10Y
C	CASI Pharmaceuticals Inc NASDAQ:CASI	Income to Minority Interest $2.6m	CAGR 3-Years 41%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Abbvie Inc NYSE:ABBV	Income to Minority Interest -$11m	CAGR 3-Years -11%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Gilead Sciences Inc NASDAQ:GILD	Income to Minority Interest $12m	CAGR 3-Years -22%	CAGR 5-Years -4%	CAGR 10-Years -6%
	Amgen Inc NASDAQ:AMGN	Income to Minority Interest N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Income to Minority Interest N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Income to Minority Interest N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

What is CASI Pharmaceuticals Inc's Income to Minority Interest?

Income to Minority Interest
2.6m USD

Based on the financial report for Dec 31, 2023, CASI Pharmaceuticals Inc's Income to Minority Interest amounts to 2.6m USD.

What is CASI Pharmaceuticals Inc's Income to Minority Interest growth rate?

Income to Minority Interest CAGR 3Y
41%

Over the last year, the Income to Minority Interest growth was -70%. The average annual Income to Minority Interest growth rates for CASI Pharmaceuticals Inc have been 41% over the past three years .

CASI Pharmaceuticals Inc
NASDAQ:CASI

CASI Pharmaceuticals Inc
Income to Minority Interest

CASI Pharmaceuticals Inc
Income to Minority Interest Peer Comparison

Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors

See Also

What is CASI Pharmaceuticals Inc's Income to Minority Interest?

Income to Minority Interest
2.6m USD

What is CASI Pharmaceuticals Inc's Income to Minority Interest growth rate?

Income to Minority Interest CAGR 3Y
41%

Company

Help

Tools

Stocks

CASI Pharmaceuticals Inc NASDAQ:CASI

CASI Pharmaceuticals Inc Income to Minority Interest

CASI Pharmaceuticals Inc Income to Minority Interest Peer Comparison

Competitive Income to Minority Interest Analysis Latest Figures & CAGR of Competitors

See Also

What is CASI Pharmaceuticals Inc's Income to Minority Interest? Income to Minority Interest 2.6m USD

What is CASI Pharmaceuticals Inc's Income to Minority Interest growth rate? Income to Minority Interest CAGR 3Y 41%

Company

Help

Tools

Stocks

CASI Pharmaceuticals Inc
NASDAQ:CASI

CASI Pharmaceuticals Inc
Income to Minority Interest

CASI Pharmaceuticals Inc
Income to Minority Interest Peer Comparison

Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors

What is CASI Pharmaceuticals Inc's Income to Minority Interest?

Income to Minority Interest
2.6m USD

What is CASI Pharmaceuticals Inc's Income to Minority Interest growth rate?

Income to Minority Interest CAGR 3Y
41%